Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.

about

Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis.

P2860

Q37457822-39D845A3-12C6-4767-8678-07FF44BBA405 Q38845950-E423698B-3675-4A4F-B7DA-BE1FAF1E2A13

P2860

Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q38736437

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Adjuvant and neoadjuvant thera ...... randomized controlled trials.

@en

type

Item

label

Adjuvant and neoadjuvant thera ...... randomized controlled trials.

@en

prefLabel

Adjuvant and neoadjuvant thera ...... randomized controlled trials.

@en

P1476

Adjuvant and neoadjuvant thera ...... f randomized controlled trials

@en

P2093

Francesco A D'Angelo

http://www.w3.org/2001/XMLSchema#string

Mara La Rocca

http://www.w3.org/2001/XMLSchema#string

Paolo Aurello

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer

The ethics of placebo-controlled trials--a middle ground

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

P2888

s12032-016-0742-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-016-0742-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036804574

http://www.w3.org/2001/XMLSchema#string

P698

26883935

http://www.w3.org/2001/XMLSchema#string

Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.

about

P2860

P2860

Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698